Cell Therapeutics, Inc. Discusses Q3 2013 Results (Webcast)

Oct.30.13 | About: CTI BioPharma (CTIC)

Cell Therapeutics (CTIC): Q3 EPS of -$0.20 misses by $0.03. Revenue of $362K. (PR)

The following audio is from a conference call that will begin on October 30, 2013 at 16:30 PM ET. The audio will stream live while the call is active, and can be replayed upon its completion.

If you would like to view a transcript of this call, please click here.